ImmunityBio (IBRX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for ImmunityBio (IBRX) over the last 12 years, with Q3 2025 value amounting to $205.1 million.
- ImmunityBio's Other Gross PP&E Adjustments rose 257.08% to $205.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.1 million, marking a year-over-year increase of 257.08%. This contributed to the annual value of $182.5 million for FY2024, which is 651.26% up from last year.
- Latest data reveals that ImmunityBio reported Other Gross PP&E Adjustments of $205.1 million as of Q3 2025, which was up 257.08% from $203.1 million recorded in Q2 2025.
- ImmunityBio's 5-year Other Gross PP&E Adjustments high stood at $205.1 million for Q3 2025, and its period low was $76.5 million during Q4 2021.
- In the last 5 years, ImmunityBio's Other Gross PP&E Adjustments had a median value of $181.9 million in 2023 and averaged $160.3 million.
- Per our database at Business Quant, ImmunityBio's Other Gross PP&E Adjustments tumbled by 776.64% in 2021 and then surged by 9106.34% in 2022.
- ImmunityBio's Other Gross PP&E Adjustments (Quarter) stood at $76.5 million in 2021, then skyrocketed by 91.06% to $146.2 million in 2022, then grew by 17.21% to $171.4 million in 2023, then rose by 6.51% to $182.5 million in 2024, then increased by 12.38% to $205.1 million in 2025.
- Its Other Gross PP&E Adjustments was $205.1 million in Q3 2025, compared to $203.1 million in Q2 2025 and $204.9 million in Q1 2025.